Rafael A. Larocca - Concepedia

Author

Rafael A. Larocca

Beth Israel Deaconess Medical Center ORCID

Also Known As

Larocca, Rafael Assumpção, R LAROCCA, R. A. Larocca, R. Larocca, R.A. Larocca, Rafael A Larocca, Rafael A. Larocca, Rafael Assumpção Larocca, Rafael Larocca

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Beth Israel Deaconess Medical Center Ragon Institute of MGH, MIT and Harvard Walter Reed Army Institute of Research Universidade de São Paulo Harvard University

About

Rafael A. Larocca is an author at Beth Israel Deaconess Medical Center specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	2.6K
2	Immunology	13	15	1.6K
3	Allergy	4	4	98
4	Cell Biology	4	4	729
5	Cellular Therapies	2	2	691

Rafael A. Larocca

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche Joji Fujisaki, Juwell W. Wu, Alicia L. Carlson, Nature Immune PrivilegeVivo ImagingCell TherapyT-regulatory CellImmunology	2011	553
Vaccine protection against Zika virus from Brazil Rafael A. Larocca, Peter Abbink, Jean Pierre Schatzmann Peron, Nature VaccinationVaccine SafetyVaccine DevelopmentVirologyMedicine	2016	514
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys Peter Abbink, Rafael A. Larocca, Rafael A. De La Barrera, Science VaccinationVaccine SafetyProtective EfficacyVaccine DevelopmentPlasmid Dna Vaccine	2016	500
Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus Monkeys Malika Aïd, Peter Abbink, Rafael A. Larocca, Cell Rhesus MonkeysNeuroanatomyNeuroinfectious DiseasesNeurovirologyViral Pathogenesis	2017	209
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials Kayvon Modjarrad, Leyi Lin, Sarah L. George, The Lancet VaccinationVaccine SafetyVaccinologyVaccine TrialPlacebo-controlled Clinical Trials	2017	193
Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs Shipra Gupta, Thomas B. Thornley, Wenda Gao, Journal of Clinical Investigation Cell TherapyImmunologyImmune RegulationRegulatory T CellsCd4 T Cell Responses	2012	138
Fetal Neuropathology in Zika Virus-Infected Pregnant Female Rhesus Monkeys Amanda J. Martinot, Peter Abbink, Onur Afacan, Cell Maternal ImmunizationFetal NeuropathologyNeurovirologyNeuroscienceFetal Complication	2018	129
Durability and correlates of vaccine protection against Zika virus in rhesus monkeys Peter Abbink, Rafael A. Larocca, Kittipos Visitsunthorn, Science Translational Medicine	2017	123
Leptin deficiency impairs maturation of dendritic cells and enhances induction of regulatory <scp>T</scp> and <scp>T</scp>h17 cells Pedro M. Moraes‐Vieira, Rafael A. Larocca, Ênio José Bassi, European Journal of Immunology	2013	97
Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors César López‐Camacho, Peter Abbink, Rafael A. Larocca, Nature Communications	2018	88

Page 1